IL148351A0 - Therapeutic immune condition compositions and methods - Google Patents

Therapeutic immune condition compositions and methods

Info

Publication number
IL148351A0
IL148351A0 IL14835100A IL14835100A IL148351A0 IL 148351 A0 IL148351 A0 IL 148351A0 IL 14835100 A IL14835100 A IL 14835100A IL 14835100 A IL14835100 A IL 14835100A IL 148351 A0 IL148351 A0 IL 148351A0
Authority
IL
Israel
Prior art keywords
methods
therapeutic immune
immune condition
condition compositions
compositions
Prior art date
Application number
IL14835100A
Original Assignee
Altarex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altarex Inc filed Critical Altarex Inc
Publication of IL148351A0 publication Critical patent/IL148351A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14835100A 1999-08-25 2000-08-25 Therapeutic immune condition compositions and methods IL148351A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15065299P 1999-08-25 1999-08-25
PCT/IB2000/002077 WO2001091792A2 (en) 1999-08-25 2000-08-25 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network

Publications (1)

Publication Number Publication Date
IL148351A0 true IL148351A0 (en) 2002-09-12

Family

ID=22535450

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14835100A IL148351A0 (en) 1999-08-25 2000-08-25 Therapeutic immune condition compositions and methods

Country Status (6)

Country Link
EP (1) EP1333859A2 (en)
JP (1) JP2004507459A (en)
AU (1) AU782952C (en)
CA (1) CA2383432A1 (en)
IL (1) IL148351A0 (en)
WO (1) WO2001091792A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007025216A2 (en) * 2005-08-25 2007-03-01 Arizona Board Of Regents On Behalf Of The University Of Arizona Stem cell fusion model of carcinogenesis
BR112022014417A2 (en) 2020-01-24 2022-09-13 Pfizer ANTI-E-SELECTIN ANTIBODIES, COMPOSITIONS AND METHODS OF USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04304897A (en) * 1991-04-01 1992-10-28 Kyowa Hakko Kogyo Co Ltd Anti-idiotype monoclonal antibody
DK0646164T3 (en) * 1992-06-15 1997-11-03 Procter & Gamble Liquid detergent compositions with silicone antifoam
IL121041A0 (en) * 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity

Also Published As

Publication number Publication date
AU9016201A (en) 2001-12-11
CA2383432A1 (en) 2001-12-06
EP1333859A2 (en) 2003-08-13
JP2004507459A (en) 2004-03-11
WO2001091792A9 (en) 2003-01-30
AU782952C (en) 2006-09-07
AU782952B2 (en) 2005-09-15
WO2001091792A2 (en) 2001-12-06
WO2001091792A3 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
HK1200316A1 (en) Therapeutic microfoams
EP1176948A4 (en) Anti-nausea compositions and methods
GB2331015B (en) Therapeutic methods and compositions involving isoflavones
HUP0200548A2 (en) Pharmaceutical compositions and their use
IL148247A (en) Vaccine composition and uses thereof
GB9924351D0 (en) Immunomodulation methods and compositions
GB9919764D0 (en) Thyristors and their manufacture
IL143423A0 (en) Insecticidal compositions and insecticidal methods
HK1044893A1 (en) Radiopharmaceutical products and their preparation procedure
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
IL146465A0 (en) Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
GB9922135D0 (en) Compositions and uses
IL148351A0 (en) Therapeutic immune condition compositions and methods
EP1194439A4 (en) Human eag2
EP1229795A4 (en) Human chemokine beta-13
EP1158856A4 (en) Human fas
AU3902600A (en) Compositions and methods for the treatment of immune related diseases
GB9903919D0 (en) Aminophenols and their therapeutic use
GB9928549D0 (en) Compositions and methods
GB9921747D0 (en) Compositions and methods
GB9916506D0 (en) Compositions and methods
GB9916503D0 (en) Compositions and methods